Nasdaq warns Nocera (NCRA) over $(440,735) equity deficit and listing risk
Rhea-AI Filing Summary
Nocera, Inc. reported receiving a Nasdaq notice that it no longer meets the required $2.5 million minimum stockholders’ equity for continued listing on The Nasdaq Capital Market. The deficiency is based on its Form 10-K for the year ended December 31, 2025, which reported stockholders’ equity of $(440,735). Nocera also does not meet Nasdaq’s alternative continued listing standards based on market value of listed securities or net income from continuing operations. The company has 45 days, until June 1, 2026, to submit a plan to regain compliance, and Nasdaq may grant up to 180 days from the notice date to demonstrate compliance. Nocera’s common stock will continue trading on The Nasdaq Capital Market under the symbol “NCRA” while it works on a compliance plan, but there is no assurance Nasdaq will accept the plan or that compliance will be regained.
Positive
- None.
Negative
- Nocera, Inc. is non-compliant with Nasdaq’s minimum stockholders’ equity requirement of $2.5 million, based on negative equity of $(440,735) as of December 31, 2025.
- The company also fails Nasdaq’s alternative continued listing standards for market value of listed securities and net income from continuing operations, increasing delisting risk if compliance is not restored.
Insights
Nasdaq equity deficiency raises delisting risk for Nocera, with a short window to present a recovery plan.
Nocera, Inc. has fallen below Nasdaq Capital Market’s minimum stockholders’ equity requirement of $2.5 million under Nasdaq Listing Rule 5550(b)(1). Its Form 10-K shows negative stockholders’ equity of $(440,735) as of December 31, 2025, and it also fails the alternative standards for market value and net income.
This places the company in a formal deficiency process. Nocera has 45 days, until June 1, 2026, to submit a remediation plan, and Nasdaq may allow up to 180 days from the notice date to evidence compliance. During this time, the shares continue to trade under symbol NCRA, but the filing explicitly notes there is no assurance that Nasdaq will accept the plan or that compliance will be regained.